Status:
COMPLETED
Cognitive Behavioral Therapy Versus Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms
Lead Sponsor:
Istanbul Nisantasi University
Conditions:
Depression, Anxiety
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; A Controlled Randomized Study. Principal Investigator: Dr. Metin Çınaroğlu, Ist...
Detailed Description
Study Title: Comparison of Cognitive Behavioral Therapy and Ericksonian Hypnosis Therapy for Depression and Anxiety Symptoms; A Controlled Randomized Study. Principal Investigator: Dr. Metin Çınaroğl...
Eligibility Criteria
Inclusion
- Age: Participants must be between 18 and 65 years old.
- Symptoms: Participants must display symptoms of depression and/or anxiety, but not necessarily have a clinical diagnosis.
- Voluntary Participation: Participants must voluntarily agree to participate and must be able to provide informed consent.
- Residency: Participants must reside in or near the study location (Istanbul) to attend in-person sessions.
- Language: Participants must be proficient in the language in which the therapy is delivered (presumably Turkish).
- Availability: Participants must be available to attend all scheduled sessions over the course of the study (12 weekly sessions).
Exclusion
- Psychiatric Diagnosis: Individuals with a severe psychiatric disorder requiring immediate or intensive intervention (e.g., schizophrenia, bipolar disorder, or severe depression with suicidal ideation).
- Current Psychotherapy: Individuals currently receiving other forms of psychotherapy or psychological treatment.
- Substance Abuse: Individuals with active substance abuse issues or dependencies that could interfere with therapy.
- Cognitive Impairments: Individuals with cognitive impairments or neurological disorders that would limit their ability to participate fully in therapy.
- Medical Conditions: Individuals with severe medical conditions that could interfere with participation in the study or pose a risk during the therapy sessions.
- Language Barrier: Non-Turkish speakers or those who do not understand the language well enough to benefit from therapy conducted in Turkish.
- Previous Participation: Individuals who have previously participated in similar studies or interventions, to avoid potential biases in responses and outcomes.
Key Trial Info
Start Date :
October 4 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2024
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06484400
Start Date
October 4 2023
End Date
November 25 2024
Last Update
January 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Metin Çınaroğlu
Istanbul, Turkey (Türkiye), 34277